Search
Enter keywords, a title or a report id number below.
Your Search for 'Drugs, Brain, and Behavior' returned 51 results - Page 1 of 3
Sort by
Sorted by
Rank
Top-Bottom
-
Alzheimer Disease - New Drugs, Markets and Companies
Jain PharmaBiotech, May 2013 , Pages: 550Alzheimer Disease - New Drugs, Markets and Companies Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world ... -
Aggression, Vol 75
Elsevier Science and Technology, Dec 2011 , Pages: 304Aggression, Vol 75 Genes interact with environment, experience, and the biology of the brain to shape an animal's behavior. This latest volume in Advances in Genetics, organized according to the most ... -
New Perspectives of Central Nervous System Injury and Neuroprotection, Vol 102
Elsevier Science and Technology, Aug 2012 , Pages: 424Repair Aruna Sharma and Hari S Sharma The Blood-Brain Barrier in Alzheimer's Disease. Novel Therapeutic Targets and Nanodrug delivery Hari S Sharma, Rudy J Castellani, Mark A Smith and Aruna ... -
The Treatment of Epilepsy. 3rd Edition
John Wiley and Sons Ltd, Jul 2009 , Pages: 1116new edition: - covers the recent advances in the principles and approaches to epilepsy therapy, the introduction of new drugs and the development of new surgical techniques - contains 26 completely ... -
Mood Modifying Drug Market
The Pharmaceutical Strategist, Mar 2012 , Pages: 65Mood Modifying Drug Market The market for mood modifying drugs, those ethical pharmaceutical drugs that treat both anxiety and depression, has been declining by an average (-4%) per year over the ... -
Biological Psychiatry. 3rd Edition
John Wiley and Sons Ltd, Sep 2010 , Pages: 432brain-behavior science, and these authors I am sure will continue to be leaders in this field, with perhaps only Lishman challenging them for the buck." (Metapsychology, 25 June 2011) "As in the ... -
Narcolepsy Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc, Jul 2010 , Pages: 160sleepiness. The global market for Narcolepsy Therapeutics is dominated by two key FDA approved drugs, Provigil and Xyrem, as stated by the new market research report on Narcolepsy Therapeutics. Provigil ... -
Epigenetics and Cancer, Part A, Vol 70
Elsevier Science and Technology, Nov 2010 , Pages: 394Epigenetics and Cancer, Part A, Vol 70 Genes interact with environment, experience, and the biology of the brain to shape an animal's behavior. This latest volume in Advances in Genetics, organized ... -
Medical Review Criteria Guidelines for Managing Care (12th edition, 2013)
Apollo Managed Care, Inc., Jan 2013 , Pages: 1260Indicators; Speed up the review process by …; Hospital Inpatient Admission Criteria, general principles; ‘Automatic' approval of authorization requests; Medical error coverage; Health and behavior assessments ... -
Neurons and Networks. An Introduction to Behavioral Neuroscience, Second Edition
Harvard University Press, May 2001 , Pages: 592Summary Further Reading 4 Action Potentials and Their Propagation The Generation of Action Potentials Voltage-Dependent Permeability Changes Voltage-Clamp Analysis Effects of Drugs on Na ... -
Stress - From Molecules to Behavior
John Wiley and Sons Ltd, Nov 2009 , Pages: 395Stress - From Molecules to Behavior This title comprehensively covers the molecular basis of stress responses of the nervous system, providing a unique and fundamental insight into the molecular ... -
Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking
TriMark Publications, Mar 2009 , Pages: 292Executive Summary 11 1.6 U.S. Sleep Market 14 1.6.1 Sleep Drugs Market in the U.S. 14 1.6.2 U.S. Sleep Apnea Devices Market 15 1.6.3 U.S. Market for Mattresses and Other related Products 15 1.6.4 Sleep ... -
Predictive ADME and Toxicology Strategies: Challenges and Opportunities for In Vivo, In Vitro and In Silico Predictive Technologies
Scripp Business Insights, Mar 2006 , Pages: 149the ADME/Tox properties early can be one method of minimizing failure. The process of drug discovery and development requires that a drug’s behavior in the human body is modelled in other systems before ... -
Annals of the New York Academy of Sciences. Addiction Reviews 2008
John Wiley and Sons Ltd, Dec 2008 , Pages: 400and Smoking: From Genes to Brain to Behavior: Francis Joseph McClernon and Scott Haden Kollins. 8. An Update on Substance Use and Treatment following Traumatic Brain Injury: David P. Graham and Aaron ... -
Standard Electroencephalography in Clinical Psychiatry. A Practical Handbook
John Wiley and Sons Ltd, Mar 2011 , Pages: 198lobe seizures and non-epileptic seizures. The clinical application of EEG in both childhood and adult disorders follows, including many case vignettes. The effects of psychotropic drugs on EEG are ... -
Mental and Neurological Public Health
Elsevier Science and Technology, Jun 2010 , Pages: 560: they are mostly mediated through brain dysfunction or abnormalities, are often chronic in course, typically benefit from multi-component interventions, and are amongst the most neglected conditions in ... -
Handbook of the Behavioral Neurobiology of Serotonin, Vol 21. Handbook of Behavioral Neuroscience
Elsevier Science and Technology, Dec 2009 , Pages: 836Section 2: The neurophysiology of serotonin 2.1 Activity of brain serotonergic neurons in relation to physiology and behavior by Barry L. Jacobs and Casimir A. Fornal 2.2 Electrophysiology of serotonin ... -
Advances in Vasopressin and Oxytocin - From Genes to Behaviour to Disease, Vol 170
Elsevier Science and Technology, Jul 2008 , Pages: 656transmitters. Moreover, the book illustrates the recent development of vasopressin and oxytocin agonists/antagonists as potential drugs to treat not only disturbances of body fluid homeostasis, but also mental ... -
Pharmacokinetics and Metabolism in Drug Design. 3rd Edition. Methods and Principles in Medicinal Chemistry
John Wiley and Sons Ltd, Apr 2012 , Pages: 268topics such as pro-drugs, active metabolites and transporters covered in detail in a manner useful to the Drug Discovery scientist. The authors discuss the parameters and processes important for the ... -
Annals of the New York Academy of Sciences. Research Frontiers Drug Addiction
John Wiley and Sons Ltd, Dec 2008 , Pages: 400new conceptual insights into the CNS acting drugs and drugs of abuse and treatment of drug addiction. Methamphetamine, MDMA, PMA and different solvents are the most widely abused drugs in the Europe ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
